<link rel="stylesheet" href="/res/styles.39be4579664c3a48.css">
Artículo

Cancer as a novel risk factor for major cardiovascular adverse events in secondary prevention

Melchiori, Renzo ; Diaz Saravia, Sara ; Rubio, Pablo M. ; Szlaien, Lucas ; Mouriño, Romina ; O'Flaherty, Martin ; Rizzo, Manglio Miguel Icon; Hita, Alejandro Icon

Otros responsables

Fecha

12/2025

Editorial

Elsevier

Revista

International Journal of Cardiology Cardiovascular Risk and Prevention

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

2772-4875

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Resumen

Introduction: The inflammatory mechanisms of cancer can be associated with atherosclerosis development andprogression. Although the incidence of events in secondary prevention following a first acute coronary syndromeis poorly documented.Methods: A retrospective cohort study including patients who underwent a coronary angiography for first AcuteCoronary Syndrome (ACS), and without prior history of Major Cardiovascular Events (MACE) from 2008 to 2023was analyzed. Included patients were grouped according to the absence or presence of cancer: G1 non-oncologic,and G2 oncologic (either prior or current history). We compared the incidence rate ratio of MACE within 3 yearsafter ACS between groups Time-to-event analysis was conducted through proportional Cox regression analysis,estimating hazard ratio, and corresponding 95 % confidence intervals (95 % CI)Results: Of 937 patients who underwent a coronary angiography, 787 patients were included, of which 88.7 % (n= 698) presented without cancer. Over a median follow-up time of 48 months [IQR = 14–72], the incidence rateof MACE was 4.4 cases per 1000 patients/months of follow-up (n = 173 MACE events). When comparing bothgroups, the incidence rate ratio of MACE was 1.9 (95 % CI 1.24–2.99), significantly increased in the cancer group(P = 0.0032). Cancer was an independent predictor of MACE after adjustment for traditional cardiovascular riskfactors (HR 1.84, 95 % CI 1.19–2.85; P = 0.006).Conclusions: Patients with cancer represent a novel independent risk factor for MACE, even following secondarypreventive therapies. These results highlight future endpoints for cardiovascular prevention and further publichealth interventions in this population.

Colecciones

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by